ABT

ABBOTT LABORATORIES

Healthcare Pharmaceutical Preparations Market cap: $181.3B All insider activity → Quote and statistics → Sign in to watch ABT Sign in to set a price alert

AI summary Insiders purchase open-market shares following a post-guidance stock sell-off.

Insider Score Band 60–79

Research score: 52
AI adjustment: +9

Research score, not a recommendation.

Total bought$1.3M3 Form 4 purchases

Distinct insiders3open-market buyers

Lead insiderBoudreau Philip PCFO

Cluster window2026-04-23 → 2026-05-07active

Market data

Live quote and chart from Yahoo Finance, loaded through this server. Insider purchases are marked on the chart.

–

Why this score

Research score: a weighted blend of the five factors, times the routine and offering discounts, minus the selling penalty.

Breadth number & diversity of participating insiders

37%

Seniority executive rank of buyers (CEO/CFO/Director)

80%

Commitment purchase size relative to company & holdings

19%

Context buying into stock weakness signals conviction

78%

Timing coordinated purchases within a tight window

88%

Routine-purchase discount × 1.00

Company-type / offering discount × 1.00

Net insider selling penalty − 6

Why are they buying?

AI · discretionary · catalyst credible · documented

Insiders likely stepped in to purchase shares following a notable dip in the stock price after Abbott cut its yearly profit forecast and received negative news surrounding litigation and guidance in mid-April 2026.

CFO Philip Boudreau and Directors Daniel Starks and John G. Stratton made open-market purchases between late April and early May 2026 right after news broke regarding lowered profit guidance following the Exact Sciences deal adjustment.

Filing references and sources

Stock Price & Insider Purchase History

Daily close price with open-market insider purchases plotted over time

Loading price history…

Transactions

3 Form 4 trades · 3 insiders Sign in to download CSV

Purchases in this cluster, grouped by insider, largest first
Date	Insider	Role	Shares	Price	Value	Filing
2026-04-27	STARKS DANIEL J 5 purchases with a 63-day result · median +2.5%	Director	10,000	$92.65	$926.5K	SEC filing for STARKS DANIEL J (opens in a new tab)
2026-04-23	Boudreau Philip P history of Boudreau Philip P's purchases	CFO	2,200	$91.50	$201.3K	SEC filing for Boudreau Philip P (opens in a new tab)
2026-05-07	Stratton John G history of Stratton John G's purchases	Director	2,000	$86.82	$173.6K	SEC filing for Stratton John G (opens in a new tab)
Total					$1.3M

What happened next

A run ends after a pause in the buying, so one company can have several. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.

After this run became a cluster: 21 days +14.9%63 days +14.0%126 days –